Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Dopamine in schizophrenia: a review and reconceptualization.

Davis KL, Kahn RS, Ko G, Davidson M.

Am J Psychiatry. 1991 Nov;148(11):1474-86. Review.

PMID:
1681750
2.

Neuroleptics, dopamine, and schizophrenia.

Pickar D.

Psychiatr Clin North Am. 1986 Mar;9(1):35-48.

PMID:
2870480
3.

Effects of metabolic perturbation on plasma homovanillic acid in schizophrenia. Relationship to prefrontal cortex volume.

Breier A, Davis OR, Buchanan RW, Moricle LA, Munson RC.

Arch Gen Psychiatry. 1993 Jul;50(7):541-50.

PMID:
8317948
4.

Plasma homovanillic acid as an index of central dopaminergic activity: studies in schizophrenic patients.

Pickar D, Breier A, Kelsoe J.

Ann N Y Acad Sci. 1988;537:339-46. Review.

PMID:
2904783
5.

Perspectives on a time-dependent model of neuroleptic action.

Pickar D.

Schizophr Bull. 1988;14(2):255-68. Review.

PMID:
2904694
6.

Down-regulation of central dopamine receptors in schizophrenia.

Zemlan FP, Hitzemann RJ, Hirschowitz J, Garver DL.

Am J Psychiatry. 1985 Nov;142(11):1334-7.

PMID:
2865903
7.

Dopamine, the prefrontal cortex and schizophrenia.

Knable MB, Weinberger DR.

J Psychopharmacol. 1997;11(2):123-31. Review.

PMID:
9208376
8.

Neurochemical and neural mechanisms of positive and negative symptoms in schizophrenia.

Pickar D, Litman RE, Konicki PE, Wolkowitz OM, Breier A.

Mod Probl Pharmacopsychiatry. 1990;24:124-51. Review.

PMID:
1970851
9.

The role of limbic and cortical regions in schizophrenia: focus on dopamine.

Marchese G, Pani L.

Eur Psychiatry. 2002 Aug;17 Suppl 4:349s-354s.

PMID:
23573604
10.

Persistent psychosis after reduction in pre- and post-synaptic dopaminergic function.

Wolkin A, Duncan E, Sanfilipo M, Wieland S, Cooper TB, Rotrosen J.

J Neural Transm Gen Sect. 1994;95(1):49-61.

PMID:
7857586
11.

Pathogenesis of schizophrenia: Part II. Temporo-frontal two-step hypothesis.

Kurachi M.

Psychiatry Clin Neurosci. 2003 Feb;57(1):9-15. Review.

12.

Monoamines and schizophrenia.

Sedvall G.

Acta Psychiatr Scand Suppl. 1990;358:7-13. Review.

PMID:
1978495
13.

Neurobiology of dopamine in schizophrenia.

Guillin O, Abi-Dargham A, Laruelle M.

Int Rev Neurobiol. 2007;78:1-39. Review.

PMID:
17349856
14.

Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment.

Pickar D, Labarca R, Doran AR, Wolkowitz OM, Roy A, Breier A, Linnoila M, Paul SM.

Arch Gen Psychiatry. 1986 Jul;43(7):669-76.

PMID:
3718170
15.

[Benzodiazepines and schizophrenia, a review of the literature].

Gaillard R, Ouanas A, Spadone C, Llorca PM, Lôo H, Baylé FJ.

Encephale. 2006 Nov-Dec;32(6 Pt 1):1003-10. Review. French.

PMID:
17372546
16.

Beyond the dopamine hypothesis. The neurochemical pathology of schizophrenia.

Reynolds GP.

Br J Psychiatry. 1989 Sep;155:305-16. Review.

PMID:
2692761
17.

Brain imaging of schizophrenia--the dopamine hypothesis.

Farde L.

Schizophr Res. 1997 Dec 19;28(2-3):157-62.

PMID:
9468350
18.

Dopamine and schizophrenia.

Crow TJ, Johnstone EC, Longden A, Owen F.

Adv Biochem Psychopharmacol. 1978;19:301-9. Review. No abstract available.

PMID:
29450
19.
20.

Dopamine in schizophrenia.

Heritch AJ.

Am J Psychiatry. 1992 Nov;149(11):1620-1. No abstract available.

PMID:
1415847

Supplemental Content

Support Center